Maija Hollmén
0000-0002-3250-7653
University of Turku
5 papers found
Refreshing results…
Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments
Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Novel Biomarkers for Diagnosing Periprosthetic Joint Infection from Synovial Fluid and Serum
Clever-1 contributes to lymphocyte entry into the spleen via the red pulp
Missing publications? Search for publications with a matching author name.